Skip to main content
Top
Published in: Calcified Tissue International 2/2017

01-02-2017 | Editorial

Diabetes and Bone

Author: Serge Ferrari

Published in: Calcified Tissue International | Issue 2/2017

Login to get access

Excerpt

Diabetes and osteoporosis are two of the most common chronic disorders which prevalence increases worldwide, eventually affecting hundreds of millions of people. The environmental, primarily nutritional, conditions that predispose to diabetes and osteoporosis, respectively, appear quite different, but there may be some common genetic factors predisposing to both disorders. Although the morphotype of subjects developing type 2 diabetes as a consequence of overweight and the metabolic syndrome seems protective against fractures, and is certainly far from the image of the frail elderly with bone fragility, type 2 diabetes is increasingly recognized as an independent risk factor for fractures—at least in the bone community, although not yet broadly recognized as a complication of glucose impairment in the diabetes community. The risk of fragility fractures is even higher among the leaner patients with type 1 diabetes, whose long-standing disease is associated with an up to fivefold higher hip fracture risk, which incidence starts to rise 10–15 years before the exponential rise observed in the non-diabetic population. The relative contribution of decreased bone strength, in particular bone “quality,” and increased incidence of injurious falls, to the higher fracture risk among diabetics remains unknown. …
Literature
1.
go back to reference Hough FS, Pierroz D, Cooper C, Ferrari S, The IOF CSA Bone and Diabetes Working Group (2016) Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur J Endocrinol 174(4):R127–R138CrossRefPubMed Hough FS, Pierroz D, Cooper C, Ferrari S, The IOF CSA Bone and Diabetes Working Group (2016) Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur J Endocrinol 174(4):R127–R138CrossRefPubMed
2.
go back to reference Nicola N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL, IOF Bone and Diabetes Working Group (2016) Mechanisms of diabetes-induced bone fragility. Nat Rev Endocrinol. doi:10.1038/nrendo.2016.153 Nicola N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL, IOF Bone and Diabetes Working Group (2016) Mechanisms of diabetes-induced bone fragility. Nat Rev Endocrinol. doi:10.​1038/​nrendo.​2016.​153
Metadata
Title
Diabetes and Bone
Author
Serge Ferrari
Publication date
01-02-2017
Publisher
Springer US
Published in
Calcified Tissue International / Issue 2/2017
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-017-0234-y

Other articles of this Issue 2/2017

Calcified Tissue International 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.